About Clinical Trials
Clinical trials are research studies that provide important information on the benefits, side effects and possible uses for medicines. Clinical trials evaluate new uses for currently available treatments or investigational drugs. In cancer research, clinical trials often study the use of combination regimens, which can include two or more approved medicines, investigational therapies or both.
Clinical trials answer important questions about potential new treatment approaches, such as:
- Does this treatment work?
- Does it work better than current options?
- What side effects does it cause?
- Do the benefits of the treatment outweigh the side effects and risks?
- Which patients are most likely to find this treatment helpful?
Health regulatory agencies, like the U.S. Food and Drug Administration, review findings from clinical trials as part of the process to determine if an investigational therapy or new combination regimen should be approved for use.
G1 adheres to standard guidelines for the use of our investigational drugs outside of current clinical trials (please see our statement on expanded access).